Regulatory Concern For Celgene's Ozanimod Could Be Big For Arena Pharma, Novartis
February 28, 2018 at 08:26 AM EST
Celgene Corporation (NASDAQ: CELG) shares plummeted 10 percent Tuesday evening after the U.S. Food and Drug Administration rejected its ...
